Information

Polyomavirus JC, multiple sclerosis, Tysabri, and an anti-malaria drug

Biogen has announced that an anti-malaria compound may be useful for treating a brain infection, progressive multifocal leukoencephalopathy (PML), that is an adverse effect of the company’s multiple sclerosis/Crohn’s disease drug Tysabri. How does JC virus fit into this story? Tysabri is the trade name for Natalizumab, a monoclonal antibody against the cellular protein alpha-4 integrin. …

Polyomavirus JC, multiple sclerosis, Tysabri, and an anti-malaria drug Read More »

TWiV #25: Viral evolution

In episode #25 of the podcast This Week in Virology, Vincent, Alan, and Luis Villarreal talk about rabies in Viet Nam and Angola, needle-stick infections with ebolavirus and West Nile virus, and viral evolution. Click the arrow above to play, or right-click to download TWiV #25 or subscribe in iTunes or by email.

Scroll to Top